查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601612

全基因组定序市场规模、占有率、预测和趋势分析：按提供（文库製备、DNA提取）、按测序类型（大规模、小规模、分阶段）、按技术（SBS、SMRT、Nanopore、Nanoball），按应用、按最终用户– 到2031 年的全球预测

Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Library Preparation, DNA Extraction) Sequencing Type (Large, Small, Phased), Technology (SBS, SMRT, Nanopore, Nanoball) Application, End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 312 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2031 年，全球全基因组定序市场将达到 71.7 亿美元，2024 年至 2031 年复合年增长率为 15.2%。

经过广泛的二次和初步研究以及对市场情景的详细分析，本报告对关键行业推动因素、阻碍因素、挑战和机会进行了分析。定序成本的下降、癌症和遗传患者病率的增加、全基因组测序在疾病诊断和精准医学中的使用增加、药品研发费用的增加以及全基因组测序在监管和报销方面的改进推动了肺活量计市场的成长。然而，全基因组定序耗材的高成本、识别精准医学积极可行变异的可能性较低，以及与全基因组定序诊断相关的伦理和法律问题正在限制该市场的成长。

此外，全基因组定序应用的增加、政府对大规模基因组定序计画的支持以及新兴国家预计将为该市场的参与者提供成长机会。然而，监管环境的不确定性、中小型实验室的专业知识和测序能力有限、新兴国家缺乏测序专家以及NGS设置所需的高资本投资已成为市场成长的重大挑战。

本报告是基于对 Masu 四年期间（2021-2024 年）产品组合供应、区域发展和关键策略发展的广泛评估，提供了竞争格局。全球全基因组定序市场的主要公司有 Illumina, Inc.（美国）、Thermo Fisher Scientific, Inc.（美国）、QIAGEN N.V.（荷兰）、F. Hoffmann-La Roche Ltd.（瑞士）、PerkinElmer , Inc.（美国）、Agilent Technologies, Inc.（美国）、Pacific Biosciences of California Inc.（美国）、Danaher Corporation（美国）、Bio-Rad Laboratories, Inc.（美国）、Oxford Nanopore Technologies Plc.（英国）、华大智造科技有限公司（中国）和北京华大基因研究院（BGI）（中国）。

在本报告研究的所有产品中，耗材领域预计将占据全基因组定序市场的最大占有率，超过 70.1%。此细分市场的庞大市占率可归因于消耗品的重复使用、试剂和目标富集方案及相关消耗品的持续进步，以及全基因组定序在临床环境中的应用不断增加。

在本报告研究的所有定序类型中，全基因组定序部分预计将在 2024 年占据全基因组定序市场的最大占有率。此细分市场拥有很大的市场占有率，因为大规模全基因组定序提供了基因组的高解析度和逐碱基视图，并可用于对大型基因组进行定序以提供群体层级的研究。

在本报告研究的所有技术中，预计到 2024 年，合成定序部分将占据全基因组定序市场的最大占有率。该领域的巨大市场占有率归因于合成测序技术的广泛采用，这些技术提供了高精度，支援双端和单红色文库，并使得高解析度基因组测序成为可能。

在本报告调查的所有应用中，研究应用预计将在 2024 年占据全基因组定序市场的最大占有率。该细分市场的巨大市场占有率归因于越来越多地使用全基因组测序来识别新的药物标靶、对基于基因的药物的需求不断增加以及对药物研发活动的需求不断增长。

在本报告研究的所有最终用户中，製药和生技公司领域预计将在 2024 年占据全基因组定序市场的最大占有率。据认为，该领域的巨大市场占有率是由于製药和生物技术公司研发支出的增加以及遗传疾病盛行率的上升，这刺激了全基因组测序在这些行业的采用。

对全球全基因组定序市场区域状况的详细分析提供了五个主要区域（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）的详细定性和定量见解，每个区域涵盖了地区主要国家。预计到 2024 年，北美将占据全基因组定序市场的最大占有率，超过 52.1%。在同一地区，2024年美国预计将占据北美全基因组定序市场的最大占有率。北美的巨大市场占有率是由全基因组测序的高度认知、支持基因组研究的有利政府举措、基于NGS的研究应用的增加、测序成本的下降、癌症的高患病率以及由于不同的赎回场景等因素而提供的支持所推动的。

调查范围：

全基因组定序市场评估：透过产品

  • 消耗品
    • 样品製备试剂盒/试剂
  • 核酸萃取/扩增
  • 文库准备/目标富集
  • 品质控制
  • 其他消耗品
  • 设备
  • 软体
  • 服务

註：其他耗材包括小瓶、移液管、容器、托盘、定序试剂、流通池、管路等。

全基因组定序市场评估：依序列类型

  • 大规模全基因组定序
  • 小规模全基因组定序
  • 人类全基因组定序
  • 其他全基因组定序类型

注意：其他全基因组定序类型包括从头定序、分阶段定序、长读长定序和逐次克隆定序。

全基因组定序市场评估：依技术

  • 依成分排列的顺序
  • 离子半导体序列
  • DNA 奈米球序列
  • 单分子即时定序
  • 其他 NGS 技术

註：其他全基因组定序技术包括奈米孔定序、AVITI 定序（Avidity 基础化学 (ABC)）。

全基因组定序市场评估：依应用划分

  • 研究和其他用途
    • 药物发现
    • 农业/动物研究
    • 其他用途
  • 临床应用
    • 生殖医学
    • 肿瘤学
    • 传染病
    • 其他临床用途

註：其他应用包括食品微生物学、饮料产业微生物组分析、环境研究等。

其他临床应用包括检测神经系统疾病、罕见疾病、代谢和免疫疾病以及食源性疾病的遗传异常。

全基因组定序市场评估<：依最终使用者/p>

  • 製药和生技公司
  • 医院/诊断实验室
  • 学术机构/研究中心
  • 其他最终用户

註：其他最终使用者主要包括法医实验室和安全机构、食品和饮料公司以及农业公司。

全基因组定序市场评估：按地区

  • 北美
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他欧洲 (RoE)
  • 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳大利亚
  • 韩国
  • 其他亚太地区 (RoAPAC)
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲 (RoLATM)
  • 中东/非洲

目录

第1章简介

第2章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 摘要
  • 影响市场成长的因素
    • 市场动态影响分析
    • 因素分析
  • 价格分析
  • 技术趋势
    • 新兴定序公司专注于改进技术和降低成本
      • Singular Genomics Systems, Inc.（美国）
      • Ultima Genomics, Inc.（美国）
      • Element Biosciences（美国）
    • 主要市场参与者对便携式即时定序技术的重视
  • 监理分析
    • 北美
      • 美国
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东
  • 波特五力分析

第 5 章全基因组定序市场评估：透过产品

  • 摘要
  • 消耗品
    • 样品製备消耗品
      • 用于文库製备和目标富集的耗材
      • 核酸萃取与扩增耗材
      • 品质管制消耗品
      • 其他试剂盒/试剂
    • 其他消耗品
  • 设备
  • 软体
  • 服务

第 6 章全基因体定序市场评估：依序列类型

  • 摘要
  • 大规模全基因组定序
  • 小规模全基因组定序
  • 分阶段序列
  • 其他全基因组定序类型

第7章全基因体定序市场评估：依应用

  • 摘要
  • 研究和其他用途
    • 药物发现
    • 农业/动物研究
    • 其他用途
  • 临床应用
    • 肿瘤学
    • 生殖医学
    • 传染病
    • 其他临床用途

第 8 章全基因体定序市场评估：依技术

  • 摘要
  • 边合成边定序 (SBS)
  • 离子半导体序列
  • 单分子即时定序
  • DNA 奈米球序列
  • 其他全基因组定序技术

第 9 章全基因体定序市场评估：依最终使用者

  • 摘要
  • 製药和生技公司
  • 医院/诊断实验室
  • 学术/研究机构
  • 其他最终用户

第 10 章全基因体定序市场评估：按地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东/非洲

第11章竞争分析

  • 摘要
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 领先企业
    • 新兴公司
  • 市占率分析（2023 年）
    • Illumina, Inc.（U.S.）
    • Thermo Fisher Scientific Inc.（U.S.）
    • MGI Tech Co., Ltd.（China）

第12章公司简介（业务概览、财务概览、产品组合、策略发展、SWOT 分析*）

  • Illumina, Inc.（U.S.）
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Oxford Nanopore Technologies Plc.
  • MGI Tech Co., Ltd.

（註：提供上位5公司的SWOT分析）

第13章 附录

Product Code: MRHC - 1041386

The global whole genome sequencing market is projected to reach $7.17 billion by 2031 at a CAGR of 15.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the declining costs of sequencing, the increasing prevalence of cancer & genetic disorders, the growing utilization of whole genome sequencing in disease diagnostics & precision medicine, increasing pharmaceutical R&D expenditures, improvements in regulatory & reimbursement scenarios for whole genome sequencing, rising healthcare expenditures, increasing funding for research activities, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of whole genome sequencing consumables, the low chances of identifying positive, actionable mutations for precision medicine, and the ethical & legal issues related to whole genome sequencing-based diagnosis restrain the growth of this market.

Furthermore, increasing applications of whole genome sequencing, government support for large-scale genomic sequencing projects, and emerging economies are expected to generate growth opportunities for the players operating in this market. However, the uncertainties in the regulatory landscape, the limited expertise & sequencing capabilities of small & medium-sized laboratories, the lack of sequencing professionals in developing countries, and the high capital investments required for NGS setups pose a major challenge to market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global whole genome sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K),MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China).

Among all the offerings studied in this report, the consumables segment is expected to account for the largest share of over 70.1% of the whole genome sequencing market. This segment's large market share can be attributed to the recurring use of consumables, continuous advancements in reagents and target enrichment protocols and associated consumables, and the increasing applications of whole genome sequencing in clinical settings.

Among all the sequencing types studied in this report, in 2024, the whole genome sequencing segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the large whole genome sequencing provides high resolution and base-by-base view of the genome and helps in sequencing large genome for providing population-level studies.

Among all the technologies studied in this report, in 2024, the sequencing by synthesis segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the widespread adoption of sequencing by synthesis technology, which offers high accuracy and supports both paired-end and single-read libraries, enabling high-resolution genome sequencing.

Among all the applications studied in this report, in 2024, the research applications segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share is attributed to the increasing use of whole genome sequencing to identify novel drug targets, the rising demand for gene-based medicines, and growing investments in drug research and development activities.

Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to increased R&D spending by pharmaceutical and biotechnology firms, along with the rising incidence of genetic diseases, which is fueling the adoption of whole genome sequencing in these industries.

An in-depth analysis of the geographical scenario of the global whole genome sequencing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 52.1% of the whole genome sequencing market. In the region in 2024, the U.S. is expected to account for the largest share of the whole genome sequencing market in North America. North America's significant market share can be attributed to factors such as high awareness of whole genome sequencing, favorable government initiatives supporting genomics research, increasing applications of NGS-based research, decreasing sequencing costs, a high prevalence of cancer, and a supportive reimbursement scenario.

Scope of the Report:

Whole Genome Sequencing Market Assessment- by Offering

  • Consumables
    • Sample Preparation Kits & Reagents
  • Nucleic Acid Extraction & Amplification
  • Library Preparation & Target Enrichment
  • Quality Control
  • Other Consumables
  • Instruments
  • Software
  • Services

Note: Other consumables include vials, pipettes, containers, trays, sequencing reagents, flow cells, and tubes.

Whole Genome Sequencing Market Assessment- by Sequencing Type

  • Large Whole-Genome Sequencing
  • Small Whole-Genome Sequencing
  • Human Whole-Genome Sequencing
  • Other Whole-Genome Sequencing Types

Note: Other Whole-genome sequencing types include De novo sequencing, Phased sequencing, Long-read sequencing, and Clone-by-clone sequencing.

Whole Genome Sequencing Market Assessment- by Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • DNA Nanoball Sequencing
  • Single-molecule Real-time Sequencing
  • Other NGS Technologies

Note: Other whole genome sequencing technologies include nanopore sequencing and AVITI sequencing (Avidity base chemistry (ABC).

Whole Genome Sequencing Market Assessment-by Application

  • Research and Other Applications
    • Drug Discovery
    • Agriculture and Animal Research
    • Other Applications
  • Clinical Applications
    • Reproductive Health
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications

Note: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.

Whole Genome Sequencing Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic Institutes & Research Centers
  • Other End Users

Note: Other end users primarily include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

Whole Genome Sequencing Market Assessment-by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Market Share Analysis
    • 2.3.3. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Pricing Analysis
  • 4.4. Technology Trends
    • 4.4.1. Emerging Sequencing Companies' Focus on Improving Technologies and Reducing Costs
      • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
      • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
      • 4.4.1.3. Element Biosciences (U.S.)
    • 4.4.2. Key Market Players' Emphasis on Portable and Real-Time Sequencing Technologies
  • 4.5. Regulatory Analysis
    • 4.5.1. North America
      • 4.5.1.1. U.S.
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East
  • 4.6. Porter's Five Forces Analysis

5. Whole Genome Sequencing Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Sample Preparation Consumables
      • 5.2.1.1. Library Preparation & Target Enrichment Consumables
      • 5.2.1.2. Nucleic Acid Extraction & Amplification Consumables
      • 5.2.1.3. Quality Control Consumables
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. Other Consumables
  • 5.3. Instruments
  • 5.4. Software
  • 5.5. Services

6. Whole Genome Sequencing Market Assessment-by Sequencing Type

  • 6.1. Overview
  • 6.2. Large Whole-Genome Sequencing
  • 6.3. Small Whole-Genome Sequencing
  • 6.4. Phased Sequencing
  • 6.5. Other Whole-Genome Sequencing Types

7. Whole Genome Sequencing Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Research & Other Applications
    • 7.2.1. Drug Discovery
    • 7.2.2. Agricultural & Animal Research
    • 7.2.3. Other Applications
  • 7.3. Clinical Applications
    • 7.3.1. Oncology
    • 7.3.2. Reproductive Health
    • 7.3.3. Infectious Diseases
    • 7.3.4. Other Clinical Applications

8. Whole Genome Sequencing Market Assessment-by Technology

  • 8.1. Overview
  • 8.2. Sequencing by Synthesis (SBS)
  • 8.3. Ion Semiconductor Sequencing
  • 8.4. Single-Molecule Real-Time Sequencing
  • 8.5. DNA Nanoball Sequencing
  • 8.6. Other Whole Genome Sequencing Technologies

9. Whole Genome Sequencing Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Hospitals & Diagnostic Laboratories
  • 9.4. Academic & Research Institutes
  • 9.5. Other End Users

10. Whole Genome Sequencing Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis (2023)
    • 11.5.1. Illumina, Inc. (U.S.)
    • 11.5.2. Thermo Fisher Scientific Inc. (U.S.)
    • 11.5.3. MGI Tech Co., Ltd. (China)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

  • 12.1. Illumina, Inc. (U.S.)
  • 12.2. Thermo Fisher Scientific Inc.
  • 12.3. F. Hoffmann-La Roche Ltd
  • 12.4. QIAGEN N.V.
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Revvity, Inc.
  • 12.7. Pacific Biosciences of California Inc.
  • 12.8. Danaher Corporation
  • 12.9. Oxford Nanopore Technologies Plc.
  • 12.10. MGI Tech Co., Ltd.

(Note: SWOT analyses of the top 5 companies will be provided.)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Number of New Cancer Cases, by Type, 2022 Vs. 2040
  • Table 2 Common Genetic Disorders: Rates of Occurrence
  • Table 4 Major Genome Sequencing Projects, by Country
  • Table 5 Health Expenditure, by Country, 2020-2022 (USD)
  • Table 6 Whole Genome Sequencing Kits & Reagents: Pricing
  • Table 7 Whole Genome Sequencing Instruments: Product Description & Pricing
  • Table 9 Ug 100 Specifications
  • Table 10 Aviti Specifications
  • Table 11 Regulatory Authorities Governing In Vitro Diagnostics, by Country/Region
  • Table 12 Global Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 13 Global Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 14 Global Whole Genome Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 16 Global Sample Preparation Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Library Preparation & Target Enrichment Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Nucleic Acid Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Quality Control Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Other Kits & Reagents Market, by Country/Region, 2022-2031" (USD Million)
  • Table 21 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Some of The Companies offering NGS Instruments for Whole Genome Sequencing are as Follows:
  • Table 23 Global Whole Genome Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Key Players offering DNA Sequencing Software
  • Table 25 Global Whole Genome Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Key Players offering Instrument-Related Services
  • Table 27 Global Whole Genome Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
  • Table 28 Global Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 29 Global Large Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Small Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Phased Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Other Whole Genome Sequencing Types Market, by Country/ Region, 2022-2031 (USD Million)
  • Table 33 Global Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 34 Global Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 35 Global Whole Genome Sequencing Market for Research & Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Whole Genome Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Whole Genome Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Whole Genome Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 40 Global Whole Genome Sequencing Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Whole Genome Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global Whole Genome Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 43 HIV Prevalence Among Adults, by Region (2020 Vs. 2022) (In Million)
  • Table 44 Global Whole Genome Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Whole Genome Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 46 Global Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 47 Global Whole Genome Sequencing Market for Sequencing by Synthesis, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global Whole Genome Sequencing Market for Ion Semiconductor Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global Whole Genome Sequencing Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Global Whole Genome Sequencing Market for DNA Nanoball Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 51 Global Whole Genome Sequencing Marker for Other Whole Genome Sequencing Technologies, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Global Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 53 Global Whole Genome Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Whole Genome Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global Whole Genome Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Whole Genome Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 58 North America: Whole Genome Sequencing Market, by Country, 2022-2031 (USD Million)
  • Table 59 North America: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 60 North America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 61 North America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 62 North America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 63 North America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 64 North America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 65 North America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 66 North America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 67 North America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 68 U.S.: Key Macroindicators & Microindicators
  • Table 69 U.S.: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 70 U.S.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 71 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 72 U.S.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 73 U.S.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 74 U.S.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 75 U.S.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 76 U.S.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 77 U.S.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 78 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments And Genome Canada Contributions, Are As Follows:
  • Table 79 Canada: Key Macroindicators & Microindicators
  • Table 80 Canada: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 81 Canada: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 82 Canada: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 83 Canada: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 84 Canada: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 85 Canada: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 86 Canada: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 87 Canada: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 88 Canada: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 89 Europe: Whole Genome Sequencing Market, by Country/Region, 2022-2031(USD Million)
  • Table 90 Europe: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 91 Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 92 Europe: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 93 Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 94 Europe: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 95 Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 96 Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 97 Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 98 Europe: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 99 Germany: Key Macroindicators & Microindicators
  • Table 100 Germany: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 101 Germany: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 102 Germany: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 103 Germany: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 104 Germany: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 105 Germany: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 106 Germany: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 107 Germany: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 108 Germany: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 109 France: Key Macroindicators & Microindicators
  • Table 110 France: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 111 France: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 112 France: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 113 France: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 114 France: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 115 France: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 116 France: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 117 France: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 118 France: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 119 U.K.: Key Macroindicators & Microindicators
  • Table 120 U.K.: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 121 U.K.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 122 U.K.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 123 U.K.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 124 U.K.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 125 U.K.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 126 U.K.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 127 U.K.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 128 U.K.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 129 Italy: Key Macroindicators & Microindicators
  • Table 130 Italy: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 131 Italy: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 132 Italy: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 133 Italy: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 134 Italy: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 135 Italy: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 136 Italy: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 137 Italy: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 138 Italy: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 139 Spain: Key Macroindicators & Microindicators
  • Table 140 Spain: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 141 Spain: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 142 Spain: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 143 Spain: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 144 Spain: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 145 Spain: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 146 Spain: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 147 Spain: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 148 Spain: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 149 Number of Sequences in Each Phase And Other Related Sequencing Information In Switzerland
  • Table 150 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 151 Rest of Europe: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 152 Rest of Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 153 Rest of Europe: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 154 Rest of Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 155 Rest of Europe: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 156 Rest of Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 157 Rest of Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 158 Rest of Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 159 Rest of Europe: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 160 Asia-Pacific: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 161 Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 162 Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 163 Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 164 Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 165 Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 166 Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 167 Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 168 Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 169 Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 170 China: Key Macroindicators & Microindicators
  • Table 171 China: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 172 China: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 173 China: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 174 China: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 175 China: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 176 China: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 177 China: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 178 China: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 179 China: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 180 Japan: Key Macroindicators & Microindicators
  • Table 181 Japan: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 182 Japan: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 183 Japan: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 184 Japan: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 185 Japan: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 186 Japan: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 187 Japan: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 188 Japan: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 189 Japan: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 190 India: Key Macroindicators & Microindicators
  • Table 191 India: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 192 India: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 193 India: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 194 India: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 195 India: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 196 India: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 197 India: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 198 India: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 199 India: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 200 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 201 Projects Funded by Australian Genomics, As Part of Its Genomic Implementation Projects In 2022 And 2023
  • Table 202 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 203 Rest of Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 204 Rest of Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 205 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 206 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 207 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 208 Rest of Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 209 Rest of Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 210 Rest of Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 211 Latin America: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 212 Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 213 Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 214 Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 215 Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 216 Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 217 Latin America: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 218 Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 219 Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 220 Latin America: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 221 Brazil: Key Macroindicators & Microindicators
  • Table 222 Brazil: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 223 Brazil: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 224 Brazil: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 225 Brazil: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 226 Brazil: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 227 Brazil: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 228 Brazil: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 229 Brazil: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 230 Brazil: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 231 Mexico: Key Macroindicators & Microindicators
  • Table 232 Mexico: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 233 Mexico: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 234 Mexico: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 235 Mexico: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 236 Mexico: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 237 Mexico: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 238 Mexico: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 239 Mexico: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 240 Mexico: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 241 Rest of Latin America: Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 242 Rest of Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 243 Rest of Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 244 Rest of Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 245 Rest of Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 246 Rest of Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 247 Rest of Latin America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 248 Rest of Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 249 Rest of Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 250 Rest of Latin America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 251 Middle East & Africa: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 252 Middle East & Africa: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 253 Middle East & Africa: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 254 Middle East & Africa: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 255 Middle East & Africa: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 256 Middle East & Africa: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 257 Middle East & Africa: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 258 Middle East & Africa: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 259 Middle East & Africa: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)

LIST OF FIGURES

  • Figure 1 Key Stakeholders
  • Figure 2 Research Process
  • Figure 3 Secondary Sources Referenced for This Study
  • Figure 4 Primary Research Techniques
  • Figure 5 Key Executives Interviewed
  • Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 7 Market Sizing and Growth forecast Approach
  • Figure 8 Global Whole Genome Sequencing Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 12 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 13 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 14 Global Whole Genome Sequencing Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2024-2031)
  • Figure 15 Global Share of Cancer Cases, by Region, 2022 Vs. 2040 (%)
  • Figure 16 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2020 Vs. 2021 (USD Million)
  • Figure 17 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
  • Figure 18 Percentage of Approved Personalized Medicines: Cancer Vs. Rare Diseases Vs. Other Diseases, 2022
  • Figure 19 USFDA Regulatory Pathways for IVD Kits
  • Figure 20 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 21 China: Medical Device Classification and Premarket Requirements for IVD Products
  • Figure 22 Porter's Five forces Analysis
  • Figure 23 Global Whole Genome Sequencing Market, by Offering, 2022 Vs. 2031 (USD Million)
  • Figure 24 Steps of Sample Preparation In A Typical Next-Generation Sequencing Workflow
  • Figure 25 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
  • Figure 26 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 27 U.S.: New Molecular Entity (NME) Approvals
  • Figure 28 Estimated Number of New Cancer Cases (Million)
  • Figure 29 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 30 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 31 Global Pharmaceutical R&D Spending, 2014-2026 (USD Million)
  • Figure 32 Pharmaceutical Spending In 2021 Vs. 2022 (In % of Health Spending)
  • Figure 33 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 34 North America: Whole Genome Sequencing Market Snapshot
  • Figure 35 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
  • Figure 36 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
  • Figure 37 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
  • Figure 38 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
  • Figure 39 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
  • Figure 40 Europe: Whole Genome Sequencing Market Snapshot
  • Figure 41 Italy: Number of Biotechnology Firms, 2014-2022
  • Figure 42 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 43 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 44 Asia-Pacific: Whole Genome Sequencing Market Snapshot
  • Figure 45 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
  • Figure 46 Japan: Number of New Molecular Entities Approved, 2014-2022
  • Figure 47 Latin America: Whole Genome Sequencing Market Snapshot
  • Figure 48 Key Growth Strategies Adopted by Leading Players, 2021- 2024
  • Figure 49 Global Whole Genome Sequencing Market: Competitive Benchmarking by Offering
  • Figure 50 Global Whole Genome Sequencing Market: Competitive Benchmarking, by Region
  • Figure 51 Competitive Dashboard: Global Whole Genome Sequencing Market
  • Figure 52 Global Whole Genome Sequencing Market Share Analysis, by Key Players, 2023 (%)
  • Figure 53 Illumina, Inc.: Financial Snapshot (2023)
  • Figure 54 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 55 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 56 QIAGEN N.V: Financial Snapshot (2023)
  • Figure 57 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 58 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 59 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 60 Danaher Corporation: Financial Snapshot (2023)
  • Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
  • Figure 62 MGI Tech Co., Ltd.: Financial Snapshot (2023)